Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bauman

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Jean-Jacques Grob, Rene Gonzalez, Nicole Basset-Seguin, et al.
Nature Methods|September 1, 2025
Functional phenotyping of genomic variants using joint multiomic single-cell DNA-RNA sequencingDominik Lindenhofer, Julia R Bauman, John A Hawkins, et al.
Dermatology and Therapy|September 24, 2021
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629Brett G M Hughes, Rene Gonzalez Mendoza, Nicole Basset-Seguin, et al.
Trials|December 9, 2025
Implementing the NYU Electronic Patient Visit Assessment (ePVA)<sup>©</sup> for head and neck cancer in rural and urban populations: a study protocol for a type 1 hybrid effectiveness-implementation clinical trialJanet H Van Cleave, Abraham A Brody, Dena Schulman-Green, et al.
Cancer|July 3, 2023
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinomaShetal A Patel, Michael K Gibson, Allison Deal, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2013
Evaluation of selective inhibitors of 11β-HSD1 for the treatment of hypertensionDavid R Bauman, Alan Whitehead, Lisa C Contino, et al.
Plos One|July 28, 2025
In vitro and in vivo characterization of wild type BMP9 and a non-osteogenic variant in models of pulmonary arterial hypertensionTobias G Schips, Karl W Kavalkovich, Lai-Ming Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, Nabil F Saba, Denise Roe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell CarcinomaDan P Zandberg, Jacob B Allred, Ari J Rosenberg, et al.
Journal of Palliative Medicine|April 13, 2021
A Pilot Study of a Collaborative Palliative and Oncology Care Intervention for Patients with Head and Neck CancerJessica R Bauman, Jessie R Panick, Thomas J Galloway, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Jean-Jacques Grob, Rene Gonzalez, Nicole Basset-Seguin, et al.
Nature Methods|September 1, 2025
Functional phenotyping of genomic variants using joint multiomic single-cell DNA-RNA sequencingDominik Lindenhofer, Julia R Bauman, John A Hawkins, et al.
Dermatology and Therapy|September 24, 2021
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629Brett G M Hughes, Rene Gonzalez Mendoza, Nicole Basset-Seguin, et al.
Trials|December 9, 2025
Implementing the NYU Electronic Patient Visit Assessment (ePVA)<sup>©</sup> for head and neck cancer in rural and urban populations: a study protocol for a type 1 hybrid effectiveness-implementation clinical trialJanet H Van Cleave, Abraham A Brody, Dena Schulman-Green, et al.
Cancer|July 3, 2023
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinomaShetal A Patel, Michael K Gibson, Allison Deal, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2013
Evaluation of selective inhibitors of 11β-HSD1 for the treatment of hypertensionDavid R Bauman, Alan Whitehead, Lisa C Contino, et al.
Plos One|July 28, 2025
In vitro and in vivo characterization of wild type BMP9 and a non-osteogenic variant in models of pulmonary arterial hypertensionTobias G Schips, Karl W Kavalkovich, Lai-Ming Yung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, Nabil F Saba, Denise Roe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell CarcinomaDan P Zandberg, Jacob B Allred, Ari J Rosenberg, et al.
Journal of Palliative Medicine|April 13, 2021
A Pilot Study of a Collaborative Palliative and Oncology Care Intervention for Patients with Head and Neck CancerJessica R Bauman, Jessie R Panick, Thomas J Galloway, et al.
Pageof 11